JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHNSON, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOHNSON, H. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 171, Issue 1, 88-97, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


NONMAST-CELL HISTAMINE KINETICS. III. UPTAKE, METABOlism AND DECLINE OF H3-HISTAMINE IN THE FEMALE RAT AND EFFECTS OF ENDOGENOUS HISTAMINE RELEASE

HOWARD L. JOHNSON 1

1 Life Sciences Research, Stanford Research Institute, Menlo Park, California

Kinetic aspects of distribution and metabolism of injected H3-histamine were studied. The decline of exogenous labeled histamine is biphasic in several tissues of the female rat while approximating a single exponential function in the pyloric stomach. The initial phase of decline, representing primarily catabolism and tissue uptake of circulating histamine, exhibits a duration of 30 to 60 minutes. Over the subsequent two-hour period the decline of both labeled histamine and total labeled metabolites is approximately logarithmic in both fed and fasted rats. In the latter, uptake of H3-histamine was increased in some tissues, and decline of labeled amine was accelerated in pyloric stomach. Tissue uptake of circulating H3-histamine was markedly reduced in anaphylaxis. The isotopic amine, however, was neither released from prelabeled tissue pools by anaphylactic mast-cell histamine release nor was its retention generally enhanced by such treatment. Conversely, nonmast-cell histamine release by reserpine pretreatment did not markedly affect catabolism and tissue uptake of circulating H3-histamine but altered the kinetics of subsequent decline of labeled amine in some tissues. The results indicate that exogenous histamine is taken up from the circulation into kinetically distinct tissue pools. The decline of H3-histamine in such pools appears to be related to in vitro histidine decarboxylase activity and may reflect the turnover of nonmast-cell histamine in several tissues.

Submitted on February 17, 1969
Accepted on October 2, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.